Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Feighner

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
International Journal of Obesity|January 1, 1987
Fluoxetine-induced weight loss in overweight non-depressed humansJ M Ferguson, J P Feighner
The Journal of Clinical Psychiatry|May 1, 1983
The use of bupropion in hospitalized depressed patientsC H Merideth, J P Feighner
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1989
Paroxetine in the treatment of depression: a comparison with imipramine and placeboJ P Feighner, W F Boyer
The Journal of Clinical Psychiatry|March 1, 1989
Plasma trimipramine levelsW F Boyer, J P Feighner
The American Journal of Psychiatry|April 1, 1974
Multimodality treatment of the hyperkinetic childA C Feighner, J P Feighner
Pharmacoeconomics|August 6, 1995
Cost analysis of paroxetine versus imipramine in major depressionJ D Bentkover, J P Feighner
Neuropsychobiology|January 1, 1989
Analysis of individual symptoms in generalized anxiety--a pooled, multistudy, double-blind evaluation of buspironeJ P Feighner, J B Cohn
The American Journal of Psychiatry|May 1, 1972
Safety of high-dose tricyclic antidepressant therapyM A Schuckit, J P Feighner
The Journal of Clinical Psychiatry|February 1, 1992
Paroxetine in the treatment of depression: a comparison with imipramine and placeboJ P Feighner, W F Boyer
International Clinical Psychopharmacology|January 1, 1993
A placebo-controlled double-blind multicenter trial of two doses of ipsapirone versus diazepam in generalized anxiety disorderW F Boyer, J P Feighner
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
International Journal of Obesity|January 1, 1987
Fluoxetine-induced weight loss in overweight non-depressed humansJ M Ferguson, J P Feighner
The Journal of Clinical Psychiatry|May 1, 1983
The use of bupropion in hospitalized depressed patientsC H Merideth, J P Feighner
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1989
Paroxetine in the treatment of depression: a comparison with imipramine and placeboJ P Feighner, W F Boyer
The Journal of Clinical Psychiatry|March 1, 1989
Plasma trimipramine levelsW F Boyer, J P Feighner
The American Journal of Psychiatry|April 1, 1974
Multimodality treatment of the hyperkinetic childA C Feighner, J P Feighner
Pharmacoeconomics|August 6, 1995
Cost analysis of paroxetine versus imipramine in major depressionJ D Bentkover, J P Feighner
Neuropsychobiology|January 1, 1989
Analysis of individual symptoms in generalized anxiety--a pooled, multistudy, double-blind evaluation of buspironeJ P Feighner, J B Cohn
The American Journal of Psychiatry|May 1, 1972
Safety of high-dose tricyclic antidepressant therapyM A Schuckit, J P Feighner
The Journal of Clinical Psychiatry|February 1, 1992
Paroxetine in the treatment of depression: a comparison with imipramine and placeboJ P Feighner, W F Boyer
International Clinical Psychopharmacology|January 1, 1993
A placebo-controlled double-blind multicenter trial of two doses of ipsapirone versus diazepam in generalized anxiety disorderW F Boyer, J P Feighner
Pageof 8